Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nimish N Vachharajani

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Cardiovascular Pharmacology|June 20, 2002
Pharmacokinetics of irbesartan are not altered in special populationsMaria R Marino, Nimish N Vachharajani
Bioanalysis|April 2, 2011
Regulated bioanalysis: an Indian perspective on harmonization effortsVikram K Ramanathan, Nimish N Vachharajani
Biopharmaceutics & Drug Disposition|May 17, 2002
On the assessment of effects of food on the pharmacokinetics of drugs in early developmentZhihong Li, Nimish N Vachharajani, Rajesh Krishna
Journal of Pharmaceutical Sciences|March 28, 2003
Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonistNimish N Vachharajani, Krishnaswamy Yeleswaram, David W Boulton
Biomedical Chromatography : BMC|February 13, 2003
Validation and application of a high-performance liquid chromatography/tandem mass spectrometry assay for sumatriptan in human plasmaDavid W Boulton, Glenn F Duncan, Nimish N Vachharajani
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2002
Validation and application of a sensitive assay for butorphanol in human plasma by high-performance liquid chromatography with tandem mass spectrometry detectionDavid W Boulton, Glenn F Duncan, Nimish N Vachharajani
Biopharmaceutics & Drug Disposition|April 5, 2002
Pharmacokinetics and dose proportionality of BMS-204352 after intravenous administration to dogsRajesh Krishna, Vinod R Shah, Subbaro Mantha, et al.
British Journal of Clinical Pharmacology|May 7, 2011
The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplaseNimish N Vachharajani, Ralph H Raymond, Wen-Chyi Shyu, et al.
Biopharmaceutics & Drug Disposition|March 14, 2002
Disposition of radiolabeled BMS-204352 in rats and dogsRajesh Krishna, Ming Yao, Nuggehally R Srinivas, et al.
Biomedical Chromatography : BMC|March 29, 2002
High performance liquid chromatographic-mass spectrometric assay for the quantitation of BMS-204352 in dog K(3)EDTA plasmaMing Yao, Subbarao Mantha, Vinod R Shah, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Pharmacology|June 20, 2002
Pharmacokinetics of irbesartan are not altered in special populationsMaria R Marino, Nimish N Vachharajani
Bioanalysis|April 2, 2011
Regulated bioanalysis: an Indian perspective on harmonization effortsVikram K Ramanathan, Nimish N Vachharajani
Biopharmaceutics & Drug Disposition|May 17, 2002
On the assessment of effects of food on the pharmacokinetics of drugs in early developmentZhihong Li, Nimish N Vachharajani, Rajesh Krishna
Journal of Pharmaceutical Sciences|March 28, 2003
Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonistNimish N Vachharajani, Krishnaswamy Yeleswaram, David W Boulton
Biomedical Chromatography : BMC|February 13, 2003
Validation and application of a high-performance liquid chromatography/tandem mass spectrometry assay for sumatriptan in human plasmaDavid W Boulton, Glenn F Duncan, Nimish N Vachharajani
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2002
Validation and application of a sensitive assay for butorphanol in human plasma by high-performance liquid chromatography with tandem mass spectrometry detectionDavid W Boulton, Glenn F Duncan, Nimish N Vachharajani
Biopharmaceutics & Drug Disposition|April 5, 2002
Pharmacokinetics and dose proportionality of BMS-204352 after intravenous administration to dogsRajesh Krishna, Vinod R Shah, Subbaro Mantha, et al.
British Journal of Clinical Pharmacology|May 7, 2011
The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplaseNimish N Vachharajani, Ralph H Raymond, Wen-Chyi Shyu, et al.
Biopharmaceutics & Drug Disposition|March 14, 2002
Disposition of radiolabeled BMS-204352 in rats and dogsRajesh Krishna, Ming Yao, Nuggehally R Srinivas, et al.
Biomedical Chromatography : BMC|March 29, 2002
High performance liquid chromatographic-mass spectrometric assay for the quantitation of BMS-204352 in dog K(3)EDTA plasmaMing Yao, Subbarao Mantha, Vinod R Shah, et al.
Pageof 2